Shang‐Min Zhang

789 total citations
10 papers, 360 citations indexed

About

Shang‐Min Zhang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Shang‐Min Zhang has authored 10 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Shang‐Min Zhang's work include Pluripotent Stem Cells Research (5 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Shang‐Min Zhang is often cited by papers focused on Pluripotent Stem Cells Research (5 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Shang‐Min Zhang collaborates with scholars based in United States and China. Shang‐Min Zhang's co-authors include Qin Yan, Jian Cao, Molly Gale, Min Lu, Lizhen Wu, Qi Xu, William K.C. Cheung, Wesley L. Cai, Jiesi Luo and Xiaoqiang Cong and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and The FASEB Journal.

In The Last Decade

Shang‐Min Zhang

10 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shang‐Min Zhang United States	8	276	50	45	40	35	10	360
Taegeun Bae South Korea	10	286 1.0×	23 0.5×	48 1.1×	46 1.1×	55 1.6×	15	415
Alişan Kayabölen Türkiye	9	163 0.6×	25 0.5×	47 1.0×	29 0.7×	23 0.7×	12	306
Madhura Kelkar India	8	319 1.2×	86 1.7×	16 0.4×	25 0.6×	41 1.2×	10	437
Benjamín García‐Bloj Chile	8	317 1.1×	58 1.2×	15 0.3×	51 1.3×	61 1.7×	13	373
Francesco Aulicino United Kingdom	11	313 1.1×	48 1.0×	36 0.8×	25 0.6×	59 1.7×	20	393
Wenxing You Hong Kong	7	403 1.5×	55 1.1×	19 0.4×	30 0.8×	121 3.5×	8	483
Yazdan Rahmati Iran	9	257 0.9×	70 1.4×	17 0.4×	133 3.3×	50 1.4×	19	333
Pablo Reyes‐Gutierrez United States	8	534 1.9×	54 1.1×	14 0.3×	50 1.3×	58 1.7×	10	627
Kirk Twaroski United States	11	274 1.0×	39 0.8×	48 1.1×	11 0.3×	76 2.2×	15	394
Mikhail A. Rubtsov Russia	11	227 0.8×	41 0.8×	9 0.2×	24 0.6×	31 0.9×	39	298

Countries citing papers authored by Shang‐Min Zhang

Since Specialization

Citations

This map shows the geographic impact of Shang‐Min Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shang‐Min Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shang‐Min Zhang more than expected).

Fields of papers citing papers by Shang‐Min Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shang‐Min Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shang‐Min Zhang. The network helps show where Shang‐Min Zhang may publish in the future.

Co-authorship network of co-authors of Shang‐Min Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shang‐Min Zhang. A scholar is included among the top collaborators of Shang‐Min Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shang‐Min Zhang. Shang‐Min Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Zhang, Shang‐Min, Jian Cao, & Qin Yan. (2023). KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic. Advances in experimental medicine and biology. 1433. 113–137. 1 indexed citations

Li, Guoliang, Thanigaivelan Kanagasabai, Wenfu Lu, et al.. (2020). KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis. Cancer Research. 80(21). 4633–4643. 43 indexed citations

Luo, Jiesi, Xiangyu Shi, Yifan Yuan, et al.. (2020). Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering. Acta Biomaterialia. 119. 184–196. 25 indexed citations

Shi, Xiangyu, Lile He, Shang‐Min Zhang, & Jiesi Luo. (2020). Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions. Stem Cell Reviews and Reports. 17(3). 862–877. 12 indexed citations

Cong, Xiaoqiang, Shang‐Min Zhang, Matthew W. Ellis, & Jiesi Luo. (2019). Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells. Stem Cells and Development. 28(19). 1288–1298. 14 indexed citations

Cong, Xiaoqiang, et al.. (2019). Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts. Stem Cells and Development. 28(24). 1581–1594. 12 indexed citations

Liu, Xiaoni, Shang‐Min Zhang, Meaghan K. McGeary, et al.. (2018). KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations. Molecular Cancer Therapeutics. 18(3). 706–717. 40 indexed citations

Yan, Qin, Shang‐Min Zhang, Katrina Meeth, Goran Micevic, & Marcus Bosenberg. (2017). Histone demethylase KDM5B is critical for PI3K‐AKT‐mTOR signaling and stemness of melanoma. The FASEB Journal. 31(S1). 1 indexed citations

Cao, Jian, Lizhen Wu, Shang‐Min Zhang, et al.. (2016). An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting. Nucleic Acids Research. 44(19). gkw660–gkw660. 165 indexed citations

10.

Guttenplan, Joseph B., Wieslawa Kosinska, Kun‐Ming Chen, et al.. (2011). Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer. International Journal of Cancer. 130(12). 2783–2790. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact